Cowen Maintains Buy on Axsome Therapeutics (AXSM) Feb 2026
AXSM analyst rating: Cowen maintains Buy and raises price target to $215; implications for investors and market context
-
-
COFORGE.NS Coforge Limited NSE 1361.00 INR After hours 24 Feb 2026: valuation gap vs AI peers
COFORGE.NS stock at 1361.00 INR on 24 Feb 2026; technical oversold and Meyka AI forecast shows 44.61% year target
-
459,595 volume spike EXR.IR ENGAGE XR EURONEXT 24 Feb 2026: Watch liquidity
EXR.IR stock intraday volume spike to 459,595 on EURONEXT; analysis of valuation, liquidity and Meyka AI forecast
-
February 24: Poland Adds Lodz to Chip Strategy, Eyes Backend Output
Poland semiconductor strategy adds Lodz and eyes backend output near Belchatow. What this means for Indian investors, supply chains, and potential Poland–Taiwan ties, with key milestones to watch.
-
CHF0.0048 intraday: MBTN.SW Meyer Burger Technology AG (SIX) 24 Feb 2026: watch volume spike
Intraday MBTN.SW stock update: CHF0.0048 price, heavy volume and Meyka AI forecast for short-term bounce
-
9984.T SoftBank Group Corp. (JPX) closed JPY 4440.00 on high volume: most-active insight
Market-closed most-active update on 9984.T stock: SoftBank closed JPY 4440.00 with heavy volume and analyst-grade outlook
-
+50.57% surge: 0947.HK MOBI at HKD 0.27 HKSE close 24 Feb 2026: watch volume
0947.HK stock jumps 50.57% to HKD 0.27 at HKSE close 24 Feb 2026; high volume may mean short-term volatility
-
U9RA.DE Under Armour (XETRA) +18.40% intraday 24 Feb 2026: active volume signals momentum
U9RA.DE stock jumps 18.40% to €7.49 intraday on 24 Feb 2026 with volume surge; technical momentum and mixed fundamentals drive watchful trading.
-
Kouri Richins Trial, February 24: Fentanyl and Finances in Focus
Kouri Richins trial: Feb. 24 openings spotlight alleged fentanyl poisoning and finances. What this Utah murder trial could mean for insurers, opioid oversight, and investor risk.
-
24 Feb 2026 AYV.SI stock -5% after hours: Acma Ltd. S$0.21 watch technicals
After-hours update: AYV.SI stock falls 5% to S$0.21 on 24 Feb 2026; technicals, Meyka forecast and valuation reviewed
